COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,283 Articles (22,759 medRxiv, 8,524 bioRxiv)

Most recent first Previous |  Page 864: Articles 8631-8640  | Next

Intranasal Nanoemulsion Adjuvanted S-2P Vaccine Demonstrates Protection in Hamsters and Induces Systemic, Cell-Mediated and Mucosal Immunity in Mice
Ganesan, S., Acosta, H., Brigolin, C., Orange, K., Trabbic, K., Chen, C., Lien, C.-E., Lin, Y.-J., Lin, M.-Y., Chuang, Y.-S., Fattom, A., Bitko, V.
10.1101/2022.03.22.485323 — Posted: 2022-03-23
In silico analysis predicts a limited impact of SARS-CoV-2 variants on CD8 T cell recognition
Isaeva, O. I., Ketelaars, S. L. C., Kvistborg, P.
10.1101/2022.03.23.485487 — Posted: 2022-03-23
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
Fang, Z., Peng, L., Lin, Q., Zhou, L., Yang, L., Feng, Y., Ren, P., Renauer, P. A., Park, J. J., Zhou, X., Wilen, C. B., Chen, S.
10.1101/2022.03.22.485418 — Posted: 2022-03-23
Jupytope: Computational extraction of structural properties of viral epitopes
Rashid, S., Ng, T. A., Kwoh, C. K.
10.1101/2022.03.22.484725 — Posted: 2022-03-23
Sequential appearance and isolation of a SARS-CoV-2 recombinant between two major SARS-CoV-2 variants in a chronically infected immunocompromised patient
Burel, E., Colson, P., Lagier, J.-C., LEVASSEUR, A., Bedotto, M., Lavrard, P., Fournier, P.-E., LA SCOLA, B., Raoult, D.
10.1101/2022.03.21.22272673 — Posted: 2022-03-23
Altered microRNA expression in severe COVID-19: potential prognostic and pathophysiological role
Garnier, N., Pollet, K., Fourcot, M., Caplan, M., Marot, G., Goutay, J., Labreuche, J., Soncin, F., Boukherroub, R., Hober, D., Lille COVID Research Network (LICORNE), , Szunerits, S., Poissy, J., Engelmann, I.
10.1101/2022.03.21.22272480 — Posted: 2022-03-23
Dynamics of anti-SARS-CoV-2 seroconversion in individual patients and at the population level
Szewczyk-Dabrowska, A., Budziar, W., Baniecki, K., Pikies, A., Harhala, M., Jedruchniewicz, N., Kazmierczak, Z., Gembara, K., Klimek, T., Witkiewicz, W., Nahorecki, A., Barczyk, K., Grata-Borkowska, U., Dabrowska, K.
10.1101/2022.03.20.22272651 — Posted: 2022-03-23
Home Care Follow up determine the point of inversion of IL-6 levels in relation to C-Reactive Protein as the cytokine storm marker in COVID-19
Mendes-Filho, S. P., Martins, F. S., Giroldi, P. J., Melo, R. H., Oliveira, E. L., Santos, A. B., Medeiros, D. C., Basano, S. A., Lopes, J. A., Chaves, Y. O., Pinheiro, R. S., Camargo, L. M., Zuliani, J. P., Nogueira, P. A.
10.1101/2022.03.21.22270828 — Posted: 2022-03-23
Burden of PCR-Confirmed SARS-CoV-2 Reinfection in the U.S. Veterans Administration, March 2020 - January 2022
VA COVID-19 Observational Research Collaboratory, , Iwashyna, T. J.
10.1101/2022.03.20.22272571 — Posted: 2022-03-23
Viral load dynamics of SARS-CoV-2 Delta and Omicron variants following multiple vaccine doses and previous infection
Woodbridge, Y., Amit, S., Huppert, A., Kopelman, N. M.
10.1101/2022.03.20.22272549 — Posted: 2022-03-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).